The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, D., Li, T., Liu, Z., Arbez, N., Yan, J., Moran, T. H., Ross, C. A., & Smith, W. W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.020 · Cited by 64
RetractedThe NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 3×
“Importantly, OS in turn enhances Aβ levels and promotes its accumulation (Lin and Beal, 2006; Xie et al., 2013).”
BackgroundAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“Once the activity of PHOX is inhibited or ROS is eliminated by scavengers, the “oxidative attack” immediately abates in most situation, which has shown a promising therapeutic effect in clinical studies (Barnham et al., 2004).”
BackgroundCrosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,537
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 3×
“While at day 14, fibrillar polymers became the main form of the protein aggregates (Zhang et al., 2005).”
BackgroundMitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Reactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047 · cited 1×
“OS is thought to be the underlying etiology that leads to cellular dysfunction and demise in both idiopathic and genetic cases of PD (Hwang, 2013; Lull and Block, 2010).”
BackgroundMitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Reddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
DJ‐1 has a role in antioxidative stress to prevent cell death
Taira, T., Saito, Y., Niki, T., Iguchi‐Ariga, S. M. M., Takahashi, K., & Ariga, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400074 · Cited by 853
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 835
Alonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L. M., Persechini, P. M., & Ojcius, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608083200 · Cited by 786
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 3×
“OH, hydroxyl radical; RCAN1, regulator of calcineurin 1; hAPP, human APP; ISF, interstitial fluid; IκB, inhibitory κB; IKKs, inhibitory κB kinase complexes; SHIP-1, SH2-containing inositol 5’-phosphatase 1; FoxO3a, Forkhead box O3; ARE, antioxidant response element; AChEIs, acetylcholinesterase inhibitors.”
BackgroundTherapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Melatonin: A peroxyl radical scavenger more effective than vitamin E
Pieri, C., Marra, M., Moroni, F., Recchioni, R., & Marcheselli, F. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00666-0 · Cited by 735
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Nrf2 regulates ROS production by mitochondria and NADPH oxidase
Kovac, S., Angelova, P. R., Holmström, K. M., Zhang, Y., Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.021 · Cited by 604
Baum, L., Lam, C. W. K., Cheung, S. K.-K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 592
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 579
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
Choi, J., Sullards, M. C., Olzmann, J. A., Rees, H. D., Weintraub, S. T., Bostwick, D. E., Gearing, M., Levey, A. I., Chin, L.-S., & Li, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509079200 · Cited by 483
DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase
Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T. M., Thomas, B., Ko, H. S., Sasaki, M., Ischiropoulos, H., Przedborski, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703219104 · Cited by 479
Synuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 2×
“Microglial cells are a dynamic immune cell population of the CNS. Evidence suggested that extracellular aggregated α-Syn activated microglia specifically (Su et al., 2008; Zhang et al., 2007).”
BackgroundNOX Enzymes in the Central Nervous System: From Signaling to Disease
Sorce, S., & Krause, K.-H. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 471
Liao, G., Zhang, M., Harhaj, E. W., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403286200 · Cited by 465
Holmström, K. M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J. M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A. T., & Abramov, A. Y. (2013) · Biology Open · doi:10.1242/bio.20134853 · Cited by 448
Reynaert, N. L., van der Vliet, A., Guala, A. S., McGovern, T., Hristova, M., Pantano, C., Heintz, N. H., Heim, J., Ho, Y.-S., Matthews, D. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603290103 · Cited by 442
The role of parkin in familial and sporadic Parkinson's disease
Dawson, T. M., & Dawson, V. L. (2010) · Movement Disorders · doi:10.1002/mds.22798 · Cited by 392
SOD2 in mitochondrial dysfunction and neurodegeneration
Flynn, J. M., & Melov, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.027 · Cited by 390 · cited 1×
“In addition to the above mentioned pathogenic factors in AD, clinical trials revealed an upregulation of SOD2 early in the progression of the disease (Flynn and Melov, 2013).”
BackgroundComplex I deficiency in Parkinson's disease frontal cortex
Parker, W. D., Parks, J. K., & Swerdlow, R. H. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.061 · Cited by 382
Proteomic and functional evidence for a P2X7 receptor signalling complex
Kim, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6347 · Cited by 379
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378
Neuroprotective Function of DJ-1 in Parkinson’s Disease
Ariga, H., Takahashi-Niki, K., Kato, I., Maita, H., Niki, T., & Iguchi-Ariga, S. M. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/683920 · Cited by 373
Beneficial role of Nrf2 in regulating NADPH generation and consumption
Wu, K. C., Cui, J. Y., & Klaassen, C. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr183 · Cited by 368
Suh, S. W., Jensen, K. B., Jensen, M. S., Silva, D. S., Kesslak, P. J., Danscher, G., & Frederickson, C. J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02096-x · Cited by 350
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease
Resende, R., Moreira, P. I., Proença, T., Deshpande, A., Busciglio, J., Pereira, C., & Oliveira, C. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.012 · Cited by 343
Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J., Yang, L., Beal, M. F., Nishimura, I., Wakamatsu, K., Ito, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504610102 · Cited by 341
Mitochondrial localization of DJ‐1 leads to enhanced neuroprotection
Junn, E., Jang, W. H., Zhao, X., Jeong, B. S., & Mouradian, M. M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21831 · Cited by 320
Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response
Nakajima, S., & Kitamura, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.020 · Cited by 307
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Tong, Y., Pisani, A., Martella, G., Karouani, M., Yamaguchi, H., Pothos, E. N., & Shen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906334106 · Cited by 304
The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction
Wilson, M. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3481 · Cited by 303
Oxidative Stress in Neurodegeneration
Shukla, V., Mishra, S. K., & Pant, H. C. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/572634 · Cited by 288
Blackinton, J., Lakshminarasimhan, M., Thomas, K. J., Ahmad, R., Greggio, E., Raza, A. S., Cookson, M. R., & Wilson, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806599200 · Cited by 275
Mondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., & Boehm, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401240 · Cited by 272
Giraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268 · cited 1×
“Pearson and colleagues reported in vivo evidence that OS increased the level of p-tau and induced the p38 MAPK pathway (Giraldo et al., 2014).”
BackgroundWang, Y., Wang, G. Z., Rabinovitch, P. S., & Tabas, I. (2014) · Circulation Research · doi:10.1161/circresaha.114.302153 · Cited by 267
DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function
Hao, L.-Y., Giasson, B. I., & Bonini, N. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911175107 · Cited by 263
Mansouri, M. T., Farbood, Y., Sameri, M. J., Sarkaki, A., Naghizadeh, B., & Rafeirad, M. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.022 · Cited by 255
Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.-Q., Bien-Ly, N., Puoliväli, J., Scearce-Levie, K., Masliah, E., & Mucke, L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0482-06.2006 · Cited by 254
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
Ludtmann, M. H. R., Angelova, P. R., Zhang, Y., Abramov, A. Y., & Dinkova-Kostova, A. T. (2014) · Biochemical Journal · doi:10.1042/bj20130863 · Cited by 240
Zhang, J., Malik, A., Choi, H. B., Ko, R. W. Y., Dissing-Olesen, L., & MacVicar, B. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.043 · Cited by 234 · cited 2×
“transmission, further leading to the depression of synaptic efficiency, which is widely considered as the leading cause of neuronal dysfunction in neurodegenerative disorders (Zhang et al., 2014).”
BackgroundThe Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System
Zeldich, E., Chen, C.-D., Colvin, T. A., Bove-Fenderson, E. A., Liang, J., Tucker Zhou, T. B., Harris, D. A., & Abraham, C. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567321 · Cited by 226
Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
Moore, D. J., Zhang, L., Dawson, T. M., & Dawson, V. L. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02265.x · Cited by 222
Dumont, M., Wille, E., Stack, C., Calingasan, N. Y., Beal, M. F., & Lin, M. T. (2009) · The FASEB Journal · doi:10.1096/fj.09-132928 · Cited by 221
Li, Q., & Engelhardt, J. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511153200 · Cited by 219
Lou, H., Jing, X., Wei, X., Shi, H., Ren, D., & Zhang, X. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.026 · Cited by 212
Dryanovski, D. I., Guzman, J. N., Xie, Z., Galteri, D. J., Volpicelli-Daley, L. A., Lee, V. M. Y., Miller, R. J., Schumacker, P. T., & Surmeier, D. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5311-12.2013 · Cited by 212
Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
P. Cardinali, D., M. Furio, A., & I. Brusco, L. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246209 · Cited by 204
Noguchi, T., Ishii, K., Fukutomi, H., Naguro, I., Matsuzawa, A., Takeda, K., & Ichijo, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708402200 · Cited by 193
DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway
Im, J.-Y., Lee, K.-W., Woo, J.-M., Junn, E., & Mouradian, M. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds131 · Cited by 193
Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in Neurons
Cherra, S. J., Steer, E., Gusdon, A. M., Kiselyov, K., & Chu, C. T. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.10.027 · Cited by 190
Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events
Wang, Y., Yang, J., & Yi, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4313 · Cited by 188
Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1
Waak, J., Weber, S. S., Waldenmaier, A., Görner, K., Alunni‐Fabbroni, M., Schell, H., Vogt‐Weisenhorn, D., Pham, T., Reumers, V., Baekelandt, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125153 · Cited by 186
Norris, E. H., Giasson, B. I., Ischiropoulos, H., & Lee, V. M.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212436200 · Cited by 181
Diverse ubiquitin signaling in NF-κB activation
Iwai, K. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.001 · Cited by 180
Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Zolezzi Moraga, J. M., Cantelli-Forti, G., & Hrelia, P. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.03.004 · Cited by 179
RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1030 · Cited by 177
Rapid cell death is preceded by amyloid plaque-mediated oxidative stress
Xie, H., Hou, S., Jiang, J., Sekutowicz, M., Kelly, J., & Bacskai, B. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217938110 · Cited by 172
P2X1and P2X5Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes
Lalo, U., Pankratov, Y., Wichert, S. P., Rossner, M. J., North, R. A., Kirchhoff, F., & Verkhratsky, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1149-08.2008 · Cited by 171
Hydrogen Peroxide Promotes Aβ Production through JNK-dependent Activation of γ-Secretase
Shen, C., Chen, Y., Liu, H., Zhang, K., Zhang, T., Lin, A., & Jing, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800013200 · Cited by 167
Fukui, M., & Zhu, B. T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.024 · Cited by 166
Ferreiro, E. B., Baldeiras, I., Ferreira, I. L., Costa, R. O., Rego, A. C., Pereira, C., & Oliveira, C. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/735206 · Cited by 165
Perfeito, R., Cunha-Oliveira, T., & Rego, A. C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.042 · Cited by 164
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease
Mondragón‐Rodríguez, S., Basurto‐Islas, G., Santa‐María, I., Mena, R., Binder, L. I., Ávila, J., Smith, M. A., Perry, G. L., & García‐Sierra, F. (2008) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00568.x · Cited by 161
Lee, D.-H., Gold, R., & Linker, R. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911783 · Cited by 160
Zhang, W., Dallas, S., Zhang, D., Guo, J., Pang, H., Wilson, B., Miller, D. S., Chen, B., Zhang, W., McGeer, P. L., et al. (2007) · Glia · doi:10.1002/glia.20532 · Cited by 160
Abdul, H. M., & Butterfield, D. A. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.006 · Cited by 160
N‐terminal acetylation is critical for forming α‐helical oligomer of α‐synuclein
Trexler, A. J., & Rhoades, E. (2012) · Protein Science · doi:10.1002/pro.2056 · Cited by 159
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 158
Amyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
Lloret, A., Badía, M.-C., Giraldo, E., Ermak, G., Alonso, M.-D., Pallardó, F. V., Davies, K. J. A., & Viña, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110890 · Cited by 157
do Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 150
ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease
Sorbi, S., Nacmias, B., Forleo, P., Latorraca, S., Gobbini, M. I., Bracco, L., Piacentini, S., & Amaducci, L. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90054-x · Cited by 148
Waak, J., Weber, S. S., Görner, K., Schall, C., Ichijo, H., Stehle, T., & Kahle, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806902200 · Cited by 148
Angeles, D. C., Gan, B.-H., Onstead, L., Zhao, Y., Lim, K., Dächsel, J. C., Melrose, H. L., Farrer, M. J., Wszołek, Z. K., Dickson, D. W., et al. (2011) · Human Mutation · doi:10.1002/humu.21582 · Cited by 147
Lim, J. H., Kim, K., Kim, S. W., Hwang, O., & Choi, H. J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.004 · Cited by 145
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Maetzler, W., Berg, D., Schalamberidze, N., Melms, A., Schott, K. J., Mueller, J. C., Liaw, L., Gasser, T., & Nitsch, C. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.020 · Cited by 144
Milani, P., Ambrosi, G., Gammoh, O. S., Blandini, F., & Cereda, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/836760 · Cited by 144
Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors
Loyer, P., Trembley, J. H., Grenet, J. A., Busson, A., Corlu, A., Zhao, W., Koçak, M., Kidd, V. J., & Lahti, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708188200 · Cited by 133
LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity
Heo, H. Y., Park, J.-M., Kim, C.-H., Han, B., Kim, K., & Seol, W. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.014 · Cited by 133
Lalo, U., Pankratov, Y., Parpura, V., & Verkhratsky, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.007 · Cited by 131
Lee, H., & Surh, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.002 · Cited by 129
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Wider, C. W., Dickson, D. W., & Wszołek, Z. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289232 · Cited by 128
P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases
Takenouchi, T., Sekiyama, K., Sekigawa, A., Fujita, M., Waragai, M., Sugama, S., Iwamaru, Y., Kitani, H., & Hashimoto, M. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0069-y · Cited by 127
Methionine-35 of A β (1–42): Importance for Oxidative Stress in Alzheimer Disease
Butterfield, D. A., & Sultana, R. (2011) · Journal of Amino Acids · doi:10.4061/2011/198430 · Cited by 124
Genetics of Parkinson's disease
Gasser, T. (2001) · Journal of Neurology · doi:10.1007/s004150170066 · Cited by 124
P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
Jiang, T., Hoekstra, J., Heng, X., Kang, W., Ding, J., Liu, J., Chen, S., & Zhang, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.015 · Cited by 123
Self-citationHatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 118
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
Billia, F., Hauck, L., Grothe, D., Konecny, F. A., Rao, V., Kim, R. H., & Mak, T. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303444110 · Cited by 115
Leoni, V. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.088 · Cited by 113
Koriyama, Y., Nakayama, Y., Matsugo, S., & Kato, S. (2013) · Brain Research · doi:10.1016/j.brainres.2012.12.041 · Cited by 113
Giaime, E., Yamaguchi, H., Gautier, C., Kitada, T., & Shen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040501 · Cited by 113
Genetics of Parkinson's disease.
Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111
Differential regulation of BACE1 expression by oxidative and nitrosative signals
Kwak, Y.-D., Wang, R., Li, J. J., Zhang, Y., Xu, H., & Liao, F. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-17 · Cited by 110
Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108
Tiong, C. X., Lu, M., & Bian, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00887.x · Cited by 108
He, P., Ouyang, X.-P., Zhou, S., Yin, W., Tang, C., Laudon, M., & Tian, S. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.04.009 · Cited by 106
Wang, Z., Liu, J., Chen, S., Wang, Y., Cao, L. H., Zhang, Y., Kang, W., Li, H., Gui, Y., Chen, S., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22514 · Cited by 105
Self-citationNADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease
Cristóvão, A. C., Guhathakurta, S., Bok, E., Je, G., Yoo, S. D., Choi, D., & Kim, Y. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2246-12.2012 · Cited by 101
DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex
Im, J., Lee, K.-W., Junn, E., & Mouradian, M. M. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.04.002 · Cited by 101
Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome
Wu, M., Bian, Q., Liu, Y., Fernandes, A. F., Taylor, A., Pereira, P., & Shang, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.021 · Cited by 99
Marcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97 · cited 2×
“Furthermore, purinergic receptor P2X7 (P2X7R) has been suggested as a new participant from studies in a rat model of PD (Marcellino et al., 2010).”
BackgroundDJ-1 Is a Copper Chaperone Acting on SOD1 Activation
Girotto, S., Cendron, L., Bisaglia, M., Tessari, I., Mammi, S., Zanotti, G., & Bubacco, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535112 · Cited by 97
Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway
Lippa, C. F., Saunders, A. M., Smith, T. W., Swearer, J. M., Drachman, D. A., Ghetti, B., Nee, L., Pulaski-Salo, D., Dickson, D., Robitaille, Y., et al. (1996) · Neurology · doi:10.1212/wnl.46.2.406 · Cited by 97
Yanagida, T., Tsushima, J., Kitamura, Y., Yanagisawa, D., Takata, K., Shibaike, T., Yamamoto, A., Taniguchi, T., Yasui, H., Taira, T., et al. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.1.7985 · Cited by 97
Structural effects of Parkinson's disease linked DJ‐1 mutations
Malgieri, G., & Eliezer, D. (2008) · Protein Science · doi:10.1110/ps.073411608 · Cited by 96
DJ-1 knock-down impairs astrocyte mitochondrial function
Larsen, N. J., Ambrosi, G., Mullett, S. J., Berman, S., & Hinkle, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.016 · Cited by 94
Pietro, V. D., Lazzarino, G., Amorini, A. M., Tavazzi, B., D’Urso, S., Longo, S. A., Vagnozzi, R., Signoretti, S., Clementi, M. E., Giardina, B., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.032 · Cited by 93
The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type
Castaño, E. M., Prelli, F., Soto, C. A., Beavis, R. C., Matsubara, E., Shoji, M., & Frangione, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32185 · Cited by 91
Deochand, M. T. C. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000128 · Cited by 90
Intermolecular disulfide bond formation in the nemo dimer requires cys54 and cys347
Herscovitch, M., Comb, W., Ennis, T., Coleman, K., Yong, S., Armstead, B., Kalaitzidis, D., Chandani, S., & Gilmore, T. D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.123 · Cited by 89
Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
Tai, L. M., Koster, K. P., Luo, J., Lee, S. H., Wang, Y.-T., Collins, N. C., Ben Aissa, M., Thatcher, G. R. J., & LaDu, M. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600833 · Cited by 89
Pan, J., Li, H., Ma, J., Tan, Y., Xiao, Q., Ding, J., & Chen, S. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-16 · Cited by 89
Self-citationDifferential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1
Görner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J. T., Beyer, K., Haass, C., & Kahle, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309204200 · Cited by 87
Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation
Pfeiffer, Z. A., Guerra, A. N., Hill, L. M., Gavala, M. L., Prabhu, U., Aga, M., Hall, D. J., & Bertics, P. J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.010 · Cited by 87
Ho, P. W., Ho, J. W.-M., Liu, H., So, D. H. ‐., Tse, Z. H., Chan, K., Ramsden, D. B., & Ho, S. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-3 · Cited by 87
Mondragón‐Rodríguez, S., Perry, G. L., Zhu, X., & Boehm, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/630182 · Cited by 86
Mullett, S. J., & Hinkle, D. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07175.x · Cited by 85
Khurana, N., & Gajbhiye, A. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.08.005 · Cited by 85
Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains
Baulac, S., Lu, H., Strahle, J. M., Yang, T., Goldberg, M. S., Shen, J., Schlossmacher, M. G., Lemere, C. A., Lu, Q., & Xia, W. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-12 · Cited by 83
Santpere, G., & Ferrer, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0478-8 · Cited by 83
Bonifati, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9324-y · Cited by 82
Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids
Jolivalt, C. G., Leininger‐Muller, B., Bertrand, P., Herber, R., Christen, Y., & Siest, G. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00232-4 · Cited by 82
Cimini, A., Moreno, S., D’Amelio, M., Cristiano, L., D’Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1199 · Cited by 82
Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation
Mirelman, A., Heman, T., Yasinovsky, K., Thaler, A., Gurevich, T., Marder, K. S., Bressman, S., Bar‐Shira, A., Orr‐Urtreger, A., Giladi, N., et al. (2013) · Movement Disorders · doi:10.1002/mds.25587 · Cited by 81
Belluzzi, E., Bisaglia, M., Lazzarini, E., Tabares, L. C., Beltramini, M., & Bubacco, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038026 · Cited by 81
Ferrer, I., Perez, E., Dalfó, E., & Barrachina, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.026 · Cited by 79
Oxidative Stress Partially Contributes to Iron-Induced Alpha-Synuclein Aggregation in SK-N-SH Cells
Li, W., Jiang, H. F., Song, N., & Xie, J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9187-x · Cited by 77
Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis
Mondragón‐Rodríguez, S., Basurto‐Islas, G., Lee, H., Perry, G. L., Zhu, X., Castellani, R. J., & Smith, M. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.27 · Cited by 77
Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., & Siciliano, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_4 · Cited by 75
Barabash, A., Marcos, A., Ancín, I., Vázquez-Álvarez, B., de Ugarte, C., Gil, P., Fernández, C., Encinas, M., López-Ibor, J. J., & Cabranes, J. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.003 · Cited by 73
Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo
Krügel, U., Kittner, H., Franke, H., & Illés, P. (2002) · Synapse · doi:10.1002/syn.10162 · Cited by 72
Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C. M., & Zuliani, G. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040003 · Cited by 70
Kemppainen, S., Lindholm, P., Galli, E., Lahtinen, H.-M., Koivisto, H., Hämäläinen, E., Saarma, M., & Tanila, H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.002 · Cited by 69
Zhou, W.-W., Lü, S., Su, Y., Xue, D., Yu, X., Wang, S., Zhang, H., Xu, P., Xie, X.-X., & Liu, R. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.013 · Cited by 68
Lee, H. P., Pancholi, N., Esposito, L., Previll, L. A., Wang, X., Zhu, X., Smith, M. A., & Lee, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028033 · Cited by 67
Why Vitamin E Therapy Fails for Treatment of Alzheimer's Disease
Brewer, G. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1238 · Cited by 66
Yang, S., Xia, C., Li, S., Du, L., Zhang, L., & Hu, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.184 · Cited by 66
Structural Impact of Three Parkinsonism-Associated Missense Mutations on Human DJ-1,
Lakshminarasimhan, M., Maldonado, M. T., Zhou, W., Fink, A. L., & Wilson, M. A. (2008) · Biochemistry · doi:10.1021/bi701189c · Cited by 66
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants
Wang, C., Cai, Y., Zheng, Z., Tang, B., Xu, Y., Wang, T., Ma, J., Chen, S., Langston, J. W., Tanner, C. M., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.05.003 · Cited by 65
Self-citationGloire, G., Charlier, E., Rahmouni, S., Volanti, C., Chariot, A., Erneux, C., & Piette, J. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209542 · Cited by 63
Salivary DJ-1 could be an indicator of Parkinson's disease progression
Kang, W., Yang, Q., Jiang, X., Chen, W., Zhang, L., Wang, X., Zhang, L., Quinn, T. J., Liu, J., & Chen, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00102 · Cited by 63
Self-citationReprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.
Satoh, T., Mckercher, S., & Lipton, S. (2014) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2013.11.002 · Cited by 62
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 62
Capturing a Reactive State of Amyloid Aggregates
Parthasarathy, S., Yoo, B., McElheny, D., Tay, W. M., & Ishii, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511345 · Cited by 62
Reitz, C., & Mayeux, R. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1255 · Cited by 61
Zhu, Y., Hoell, P., Ahlemeyer, B., Sure, U., Bertalanffy, H., & Krieglstein, J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.010 · Cited by 61
Resveratrol Protects PC12 Cells from High Glucose-Induced Neurotoxicity Via PI3K/Akt/FoxO3a Pathway
Liu, M., Yuan, C., He, J., TAN, T.-P., WU, S.-J., FU, H.-Y., Liu, J., Yu, S., Chen, Y.-D., Le, Q.-F., et al. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0147-5 · Cited by 61
Safarian, F., Khallaghi, B., Ahmadiani, A., & Dargahi, L. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0478-1 · Cited by 61
Maita, C., Maita, H., Iguchi‐Ariga, S. M. M., & Ariga, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054087 · Cited by 60
Li, D.-Z., Zhang, Q.-X., Dong, X., Li, H., & Ma, X. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0530-1 · Cited by 59
Hracskó, Z., Baranyi, M., Csölle, C., Gölöncsér, F., Madarász, E., Kittel, Á., & Sperlágh, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-28 · Cited by 59
Regulation of cerebral metabolism during cortical spreading depression
Feuerstein, D., Backes, H., Gramer, M., Takagaki, M., Gabel, P., Kumagai, T., & Graf, R. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15612779 · Cited by 59
Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands
Nagasawa, K., Escartin, C., & Swanson, R. A. (2008) · Glia · doi:10.1002/glia.20791 · Cited by 57
The nigrostriatal DA pathway and Parkinson’s disease
Fuxé, K., Manger, P. R., Genedani, S., & Agnati, L. F. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_13 · Cited by 55
Martel‐Gallegos, G., Casas‐Pruneda, G., Ortega, F., Sánchez‐Armass, S., Olivares-Reyes, J. A., Diebold, B. A., Pérez‐Cornejo, P., & Arreola, J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.023 · Cited by 55
NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
Hernandes, M. S., Café-Mendes, C. C., & Britto, L. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/157857 · Cited by 54
Sinem, F., Konukoğlu, D., Gokhan, E., Melda, B., Orhan, Y., & Filiz, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383822 · Cited by 54
DJ-1 cooperates with PYCR1 in cell protection against oxidative stress
Yasuda, T., Kaji, Y., Agatsuma, T., Niki, T., Arisawa, M., Shuto, S., Ariga, H., & Iguchi‐Ariga, S. M. M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.095 · Cited by 53
Raichur, A. M., Vali, S., & Gorin, F. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.052 · Cited by 53
The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease
Cao, L. H., Zhang, T., Xiao, Q., Wang, Y., Bai, L., Lu, G., Fang, J., Zhang, J., Ding, J. Q., & Chen, S. D. (2007) · Movement Disorders · doi:10.1002/mds.21763 · Cited by 53
Self-citationParkin mutations in familial and sporadic Parkinson's disease among Indians
Chaudhary, S., Behari, M., Dihana, M., Swaminath, P. V., Govindappa, S. T., Jayaram, S., Goyal, V., Maitra, A., Muthane, U. B., Juyal, R. C., et al. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.12.004 · Cited by 52
Cited by
Protein misfolding in neurodegenerative diseases: Implications and strategies
Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0077-5 · Cited by 675
Ageing, age-related diseases and oxidative stress: What to do next?
Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581
“related proteins including α-Synuclein, Parkin, DJ-1, PINK1, LRRK2 and HTRA2 were associated with mitochondrial dysfunction as well (Jiang et al., 2016; Lin and Beal, 2006).”
BackgroundGonzález-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Neuroprotective Effect of Antioxidants in the Brain
Lee, K. H., Cha, M., & Lee, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197152 · Cited by 502
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère, N., Burke Nanni, S., & Trudeau, L.-E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00455 · Cited by 413
Metadata
- Authors
- Jiang, T., Sun, Q., & Chen, S.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 147
- Pages
- 1-19
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2535730691
- Cited by
- 586
- References
- 232
- FWCI
- 37.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.